Phase 1/2 Study of Amcenestrant (SAR439859) Single Agent and in Combination With Other Anti-cancer Therapies in Postmenopausal Women With Estrogen Receptor Positive Advanced Breast Cancer
Clinical trial NCT03284957 · TERMINATED
Trial details
- NCT number
- NCT03284957
- Sponsor
- Sanofi
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-20
- Primary completion
- 2024-11-08
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.